COVID-19 Vaccine Acceptance of Pregnant and Lactating Women (PLW) in Czechia: An Analytical Cross-Sectional Study
COVID-19 Vaccines Safety Tracking (CoVaST): Protocol of a Multi-Center Prospective Cohort Study for Active Surveillance of COVID-19 Vaccines’ Side Effects
The methodological protocol "COVID-19 Vaccines Safety Tracking (CoVaST): Protocol of Multi-Center Prospective Cohort Sudy for Active Surveillance of COVId-19 Vaccines´Side Effects" of the sudy is open-access. The results are being published in scientific journals with open access as cross-sectional studies.
Authors: RIAD Abanoub, Holger SCHÜNEMANN, Sameh ATTIA, Tina POKLEPOVIĆ PERIČIĆ, Marija Franka ŽULJEVIĆ, Mikk JÜRISSON, Ruth KALDA, Katrin LANG, Sudhakar MORANKAR, Elias Ali YESUF, Mohamed MEKHEMAR, Anthony DANSO-APPIAH, Ahmad SOFI-MAHMUDI, Giordano PÉREZ-GAXIOLA, Arkadiusz DZIEDZIC, João APÓSTOLO, Daniela CARDOSO, Janja MARC, Mayte MORENO-CASBAS, Charles Shey WIYSONGE, Amir QASEEM, Anna GRYSCHEK, Ivana TADIĆ, Mohammad Salman HUSSAIN, Mohammed Ahmed KHAN, Jitka KLUGAROVA, Andrea POKORNÁ, Michal KOŠČÍK and Miloslav KLUGAR.
Year of publication: 2021
Type: Article in Periodical
Magazine / Source: International Journal of Environmental Research and Public Health
Web: https://www.mdpi.com/1660-4601/18/15/7859
Doi: http://dx.doi.org/10.3390/ijerph18157859
Keywords: cohort studies; cross-sectional studies; COVID-19; drug-related side effects and adverse reactions; health personnel; mass vaccination; prevalence
Abstract
Background: Coronavirus disease (COVID-19) vaccine-related side effects have a determinant role in the public decision regarding vaccination. Therefore, this study has been designed to actively monitor the safety and effectiveness of COVID-19 vaccines globally. Methods: A multi-country, three-phase study including a cross-sectional survey to test for the short-term side effects of COVID-19 vaccines among target population groups. In the second phase, we will monitor the booster doses’ side effects, while in the third phase, the long-term safety and effectiveness will be investigated. A validated, self-administered questionnaire will be used to collect data from the target population; Results: The study protocol has been registered at ClinicalTrials.gov, with the identifier NCT04834869. Conclusions: CoVaST is the first independent study aiming to monitor the side effects of COVID-19 vaccines following booster doses, and the long-term safety and effectiveness of said vaccines.
For full-text click on the button